Literature DB >> 24420862

Genetic analysis of the ATP1B4 gene in Chinese Han patients with Parkinson's disease.

Kai Gao1, Zhi Song, Hui Liang, Wen Zheng, Xiong Deng, Yi Yuan, Yongxiang Zhao, Hao Deng.   

Abstract

Parkinson's disease (PD) is the second most common neurodegenerative disease characterized clinically by bradykinesia, resting tremor, rigidity and postural instability. Mutations in the ATPase 13A2 gene were found to be the causes for the Kufor-Rakeb syndrome, a rare form of recessively inherited atypical juvenile parkinsonism. The ATPase Na(+)/K(+) transporting beta 4 polypeptide gene (ATP1B4) is located within a 19-centimorgen region of the PARK12 near the marker DXS1001 and it encodes a protein named βm, a member of P-type ATPases β-subunit family. To determine whether mutations in the ATP1B4 gene are associated with PD, we screened the coding region of this gene in 100 Chinese Han patients with PD. A known single nucleotide variant rs2072452 (c.143T > C), predicted to lead to amino acid substitution (p.Val48Ala), was identified. Extended analysis of 202 patients with PD and 400 gender, age, and ethnicity matched healthy controls showed no significant differences between patients and control subjects for genotypic and allelic distributions (P = 0.638 for genotypic distribution; P = 0.685 for allelic distribution in females and P = 0.303 for allelic distribution in males), suggesting the variant in the coding region of the ATP1B4 gene may play little or no role in the development of PD in Chinese Han population.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24420862     DOI: 10.1007/s11033-014-3084-y

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  28 in total

Review 1.  Role of mendelian genes in "sporadic" Parkinson's disease.

Authors:  Suzanne Lesage; Alexis Brice
Journal:  Parkinsonism Relat Disord       Date:  2012-01       Impact factor: 4.891

2.  Juvenile dystonia-parkinsonism and dementia caused by a novel ATP13A2 frameshift mutation.

Authors:  David Crosiers; Berten Ceulemans; Bram Meeus; Karen Nuytemans; Philippe Pals; Christine Van Broeckhoven; Patrick Cras; Jessie Theuns
Journal:  Parkinsonism Relat Disord       Date:  2010-11-20       Impact factor: 4.891

Review 3.  P-type ATPases.

Authors:  Michael G Palmgren; Poul Nissen
Journal:  Annu Rev Biophys       Date:  2011       Impact factor: 12.981

4.  ATP13A2 variability in Taiwanese Parkinson's disease.

Authors:  Chiung-Mei Chen; Chih-Hsin Lin; Hsueh-Fen Juan; Fen-Ju Hu; Ya-Chin Hsiao; Hsin-Yi Chang; Chih-Ying Chao; I-Cheng Chen; Li-Ching Lee; Tsu-Wei Wang; Ya-Tang Chen; Yi-Tsun Chen; Guey-Jen Lee-Chen; Yih-Ru Wu
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2011-06-28       Impact factor: 3.568

5.  PARK9-associated ATP13A2 localizes to intracellular acidic vesicles and regulates cation homeostasis and neuronal integrity.

Authors:  David Ramonet; Agata Podhajska; Klodjan Stafa; Sarah Sonnay; Alzbeta Trancikova; Elpida Tsika; Olga Pletnikova; Juan C Troncoso; Liliane Glauser; Darren J Moore
Journal:  Hum Mol Genet       Date:  2011-12-20       Impact factor: 6.150

6.  Hereditary parkinsonism with dementia is caused by mutations in ATP13A2, encoding a lysosomal type 5 P-type ATPase.

Authors:  Alfredo Ramirez; André Heimbach; Jan Gründemann; Barbara Stiller; Dan Hampshire; L Pablo Cid; Ingrid Goebel; Ammar F Mubaidin; Abdul-Latif Wriekat; Jochen Roeper; Amir Al-Din; Axel M Hillmer; Meliha Karsak; Birgit Liss; C Geoffrey Woods; Maria I Behrens; Christian Kubisch
Journal:  Nat Genet       Date:  2006-09-10       Impact factor: 38.330

7.  ATP13A2 variants in early-onset Parkinson's disease patients and controls.

Authors:  Ana Djarmati; Johann Hagenah; Kathrin Reetz; Susen Winkler; Maria Isabel Behrens; Heike Pawlack; Katja Lohmann; Alfredo Ramirez; Vera Tadić; Norbert Brüggemann; Daniela Berg; Hartwig R Siebner; Anthony E Lang; Peter P Pramstaller; Ferdinand Binkofski; Vladimir S Kostić; Jens Volkmann; Thomas Gasser; Christine Klein
Journal:  Mov Disord       Date:  2009-10-30       Impact factor: 10.338

Review 8.  Neurodegenerative diseases and oxidative stress.

Authors:  Kevin J Barnham; Colin L Masters; Ashley I Bush
Journal:  Nat Rev Drug Discov       Date:  2004-03       Impact factor: 84.694

9.  Novel ATP13A2 (PARK9) homozygous mutation in a family with marked phenotype variability.

Authors:  Lucio Santoro; Guido J Breedveld; Fiore Manganelli; Rosa Iodice; Chiara Pisciotta; Maria Nolano; Francesca Punzo; Mario Quarantelli; Sabina Pappatà; Alessio Di Fonzo; Ben A Oostra; Vincenzo Bonifati
Journal:  Neurogenetics       Date:  2010-09-21       Impact factor: 2.660

10.  ATP13A2 missense mutations in juvenile parkinsonism and young onset Parkinson disease.

Authors:  A Di Fonzo; H F Chien; M Socal; S Giraudo; C Tassorelli; G Iliceto; G Fabbrini; R Marconi; E Fincati; G Abbruzzese; P Marini; F Squitieri; M W Horstink; P Montagna; A Dalla Libera; F Stocchi; S Goldwurm; J J Ferreira; G Meco; E Martignoni; L Lopiano; L B Jardim; B A Oostra; E R Barbosa; V Bonifati
Journal:  Neurology       Date:  2007-05-08       Impact factor: 9.910

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.